Skip to main content
Caplight Logo









InFocus Therapeutics

InFocus Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.infocustx.com/

Last Round

Accelerator

Sep 2, 2025

Company Overview

InFocus Therapeutics is a biotechnology company that develops an AI-powered drug discovery platform to identify and optimize RNA-targeting small molecule therapeutics for oncology and neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

RNA-targeted therapeuticssmall-molecule drug discoverygenerative AI drug discoveryAI-powered biotechRNA splice modulatorsAI drug discoveryin silico drug designcomputational chemistrylead optimizationdrug discovery platformAI-first biotechbiotech startuponcology drug discoveryneuroscience drug discoveryAI-driven R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InFocus Therapeutics Comparables

Compare InFocus Therapeutics with similar companies based on industry and business-model similarity.

InFocus Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Serna Bio
91%
ReviR Therapeutics
89%
Atomic AI
86%

InFocus Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 2, 2025
AngelJul 2, 2025
AcceleratorJun 5, 2025
GrantJul 23, 2024
AcceleratorApr 10, 2024

Key People

Founding team and executive leadership

Dirk Tomandl

Co-Founder, CTO

Founding Team

Emily Fang

President and CEO

Executive Team

Johnny Yu

Chief Financial Officer

Executive Team

InFocus Therapeutics Investors

Notable investors and investment history

InFocus Therapeutics investors
InvestorRounds
Berkeley SkyDeckAccelerator
Taiwan Tech ArenaAccelerator
Mosaic Venture LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2025

    $1M raised in an Angel round.

  • Jun 5, 2025

    Mosaic Venture Lab led the funding round.

InFocus Therapeutics Filings

Explore SEC and related filing metadata, where available.

InFocus Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InFocus Therapeutics's valuation, stock price, and market status.

Is InFocus Therapeutics a public or private company?

InFocus Therapeutics is a private company.

What is the current stock price of InFocus Therapeutics?

InFocus Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is InFocus Therapeutics worth (valuation)?

Valuation information for InFocus Therapeutics is not publicly available.

Can I buy InFocus Therapeutics stock?

InFocus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was InFocus Therapeutics's last funding round?

InFocus Therapeutics's most recent funding round was Accelerator on September 2, 2025.

Who are the main investors in InFocus Therapeutics?

Key investors in InFocus Therapeutics include Mosaic Venture Lab.

Will InFocus Therapeutics IPO soon?

No public IPO plans have been announced for InFocus Therapeutics.

How can I track InFocus Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InFocus Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range7
Year Founded2023
Last FundingSep 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?